Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Bacterial biofilm formation on indwelling urethral catheters.

Pelling H, Nzakizwanayo J, Milo S, Denham EL, MacFarlane WM, Bock LJ, Sutton JM, Jones BV.

Lett Appl Microbiol. 2019 Apr;68(4):277-293. doi: 10.1111/lam.13144. Review.

PMID:
30811615
2.

SmvA is an important efflux pump for cationic biocides in Klebsiella pneumoniae and other Enterobacteriaceae.

Wand ME, Jamshidi S, Bock LJ, Rahman KM, Sutton JM.

Sci Rep. 2019 Feb 4;9(1):1344. doi: 10.1038/s41598-018-37730-0.

3.

Bacterial biocide resistance: a new scourge of the infectious disease world?

Bock LJ.

Arch Dis Child. 2019 Jan 31. pii: archdischild-2018-315090. doi: 10.1136/archdischild-2018-315090. [Epub ahead of print] No abstract available.

PMID:
30705078
4.

Pseudomonas aeruginosa adapts to octenidine in the laboratory and a simulated clinical setting, leading to increased tolerance to chlorhexidine and other biocides.

Shepherd MJ, Moore G, Wand ME, Sutton JM, Bock LJ.

J Hosp Infect. 2018 Nov;100(3):e23-e29. doi: 10.1016/j.jhin.2018.03.037. Epub 2018 Mar 31.

PMID:
29614247
5.

Growth media and assay plate material can impact on the effectiveness of cationic biocides and antibiotics against different bacterial species.

Bock LJ, Hind CK, Sutton JM, Wand ME.

Lett Appl Microbiol. 2018 May;66(5):368-377. doi: 10.1111/lam.12863. Epub 2018 Mar 22.

PMID:
29432643
6.

Retention of virulence following colistin adaptation in Klebsiella pneumoniae is strain-dependent rather than associated with specific mutations.

Wand ME, Bock LJ, Sutton JM.

J Med Microbiol. 2017 Jul;66(7):959-964. doi: 10.1099/jmm.0.000530. Epub 2017 Jul 21.

PMID:
28741998
7.

Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.

Wand ME, Bock LJ, Bonney LC, Sutton JM.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01162-16. doi: 10.1128/AAC.01162-16. Print 2017 Jan.

8.

Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains.

Bock LJ, Wand ME, Sutton JM.

J Hosp Infect. 2016 May;93(1):42-8. doi: 10.1016/j.jhin.2015.12.019. Epub 2016 Jan 21.

PMID:
26899354
9.

Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.

Wand ME, Bock LJ, Bonney LC, Sutton JM.

J Antimicrob Chemother. 2015 Aug;70(8):2209-16. doi: 10.1093/jac/dkv097. Epub 2015 Apr 22.

PMID:
25904728
10.

Evaluation of the effectiveness of hydrogen-peroxide-based disinfectants on biofilms formed by Gram-negative pathogens.

Perumal PK, Wand ME, Sutton JM, Bock LJ.

J Hosp Infect. 2014 Aug;87(4):227-33. doi: 10.1016/j.jhin.2014.05.004. Epub 2014 Jun 5.

PMID:
24957804
11.

Application of rapid read-out cleaning indicators for improved process control in hospital sterile services departments.

Nugent PG, Modi T, McLeod N, Bock LJ, Smith C, Poolman TM, Warburton R, Meighan P, Wells P, Sutton JM.

J Hosp Infect. 2013 May;84(1):59-65. doi: 10.1016/j.jhin.2012.12.015. Epub 2013 Apr 4.

PMID:
23562452
12.

Cnn1 inhibits the interactions between the KMN complexes of the yeast kinetochore.

Bock LJ, Pagliuca C, Kobayashi N, Grove RA, Oku Y, Shrestha K, Alfieri C, Golfieri C, Oldani A, Dal Maschio M, Bermejo R, Hazbun TR, Tanaka TU, De Wulf P.

Nat Cell Biol. 2012 May 6;14(6):614-24. doi: 10.1038/ncb2495. Erratum in: Nat Cell Biol. 2013 Mar;15(3):335.

13.

Acinetobacter baumannii virulence is enhanced in Galleria mellonella following biofilm adaptation.

Wand ME, Bock LJ, Turton JF, Nugent PG, Sutton JM.

J Med Microbiol. 2012 Apr;61(Pt 4):470-7. doi: 10.1099/jmm.0.037523-0. Epub 2011 Dec 22.

PMID:
22194338
14.

Practice brief. Management practices for the release of information.

Bock LJ, Demster B, Dinh AK, Gorton ER, Lantis JR Jr.

J AHIMA. 2008 Nov-Dec;79(11):77-80. No abstract available.

PMID:
19115738
15.

Paper 2.

Bock LJ.

Aust J Physiother. 1973 Dec;19(4):144-5. doi: 10.1016/S0004-9514(14)61161-2.

Supplemental Content

Support Center